The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19

The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.11195-11196
Hauptverfasser: Nishikubo, Masashi, Shimomura, Yoshimitsu, Nagai, Yuya, Kondo, Tadakazu, Ishikawa, Takayuki
Format: Artikel
Sprache:eng
Schlagworte:
Online Publication Only
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11196
container_issue Supplement 1
container_start_page 11195
container_title Blood
container_volume 140
creator Nishikubo, Masashi
Shimomura, Yoshimitsu
Nagai, Yuya
Kondo, Tadakazu
Ishikawa, Takayuki
description
doi_str_mv 10.1182/blood-2022-166433
format Article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9665265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122066058</els_id><sourcerecordid>S0006497122066058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1923-c2c50cce3c068cbc371e4260a756173053949df606cf0acfefd16deef137773</originalsourceid><addsrcrecordid>eNp9kd2O0zAQhS0EEmWXB-BuLuEirH8SpxESEqTsj7SwSK24tRxn0holdmW7RX23fbh12xUSN1xZGs93zswcQt4x-pGxOb_qRu_7glPOCyZlKcQLMmMVnxeUcvqSzCilsiibmr0mb2L8TSkrBa9m5HG1QVjsgk7WO_ADtD54p_c27CIsbEQdEThlDbxvH37dLQrWfIB2RB20MwjWwc-MoksR_ti0gVucdPKjX1ujR_iuR7t2udNihFY76BCW6Wg2WOzh6wFStv-xmzoMJ_MNTj6Xgt4eYBVQpylLg3Y9LHGPwabDqe15kkvyatBjxLfP7wVZXn9btbfF_cPNXfvlvjCs4aIw3FTUGBSGyrnpjKgZllxSXVeS1YJWoimbfpBUmoFqM-DQM9kjDkzUdS0uyOez6nbXTdibPFHQo9oGO-lwUF5b9e-Psxu19nvVSFlxWWUBdhYwwccYcPjLMqqO6alTeuqYnjqnl5lPZwbzXnuLQcV8xHzy3gY0SfXe_od-Ao_HpNk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Nishikubo, Masashi ; Shimomura, Yoshimitsu ; Nagai, Yuya ; Kondo, Tadakazu ; Ishikawa, Takayuki</creator><creatorcontrib>Nishikubo, Masashi ; Shimomura, Yoshimitsu ; Nagai, Yuya ; Kondo, Tadakazu ; Ishikawa, Takayuki</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-166433</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Online Publication Only</subject><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.11195-11196</ispartof><rights>2022 The American Society of Hematology</rights><rights>Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. 2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids></links><search><creatorcontrib>Nishikubo, Masashi</creatorcontrib><creatorcontrib>Shimomura, Yoshimitsu</creatorcontrib><creatorcontrib>Nagai, Yuya</creatorcontrib><creatorcontrib>Kondo, Tadakazu</creatorcontrib><creatorcontrib>Ishikawa, Takayuki</creatorcontrib><title>The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19</title><title>Blood</title><subject>Online Publication Only</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kd2O0zAQhS0EEmWXB-BuLuEirH8SpxESEqTsj7SwSK24tRxn0holdmW7RX23fbh12xUSN1xZGs93zswcQt4x-pGxOb_qRu_7glPOCyZlKcQLMmMVnxeUcvqSzCilsiibmr0mb2L8TSkrBa9m5HG1QVjsgk7WO_ADtD54p_c27CIsbEQdEThlDbxvH37dLQrWfIB2RB20MwjWwc-MoksR_ti0gVucdPKjX1ujR_iuR7t2udNihFY76BCW6Wg2WOzh6wFStv-xmzoMJ_MNTj6Xgt4eYBVQpylLg3Y9LHGPwabDqe15kkvyatBjxLfP7wVZXn9btbfF_cPNXfvlvjCs4aIw3FTUGBSGyrnpjKgZllxSXVeS1YJWoimbfpBUmoFqM-DQM9kjDkzUdS0uyOez6nbXTdibPFHQo9oGO-lwUF5b9e-Psxu19nvVSFlxWWUBdhYwwccYcPjLMqqO6alTeuqYnjqnl5lPZwbzXnuLQcV8xHzy3gY0SfXe_od-Ao_HpNk</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Nishikubo, Masashi</creator><creator>Shimomura, Yoshimitsu</creator><creator>Nagai, Yuya</creator><creator>Kondo, Tadakazu</creator><creator>Ishikawa, Takayuki</creator><general>Elsevier Inc</general><general>The American Society of Hematology. Published by Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20221115</creationdate><title>The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19</title><author>Nishikubo, Masashi ; Shimomura, Yoshimitsu ; Nagai, Yuya ; Kondo, Tadakazu ; Ishikawa, Takayuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1923-c2c50cce3c068cbc371e4260a756173053949df606cf0acfefd16deef137773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Online Publication Only</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nishikubo, Masashi</creatorcontrib><creatorcontrib>Shimomura, Yoshimitsu</creatorcontrib><creatorcontrib>Nagai, Yuya</creatorcontrib><creatorcontrib>Kondo, Tadakazu</creatorcontrib><creatorcontrib>Ishikawa, Takayuki</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nishikubo, Masashi</au><au>Shimomura, Yoshimitsu</au><au>Nagai, Yuya</au><au>Kondo, Tadakazu</au><au>Ishikawa, Takayuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>11195</spage><epage>11196</epage><pages>11195-11196</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-166433</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.11195-11196
issn 0006-4971
1528-0020
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9665265
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Online Publication Only
title The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T22%3A41%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Duration%20of%20Coronavirus%20Disease%202019%20(COVID-19)%20Clearance%20in%20Patients%20with%20Hematological%20Malignancies%20Can%20be%20Stratified%20By%20the%20Number%20of%20Chemotherapy%20Treatment%20and%20Severity%20of%20COVID-19&rft.jtitle=Blood&rft.au=Nishikubo,%20Masashi&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=11195&rft.epage=11196&rft.pages=11195-11196&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-166433&rft_dat=%3Celsevier_pubme%3ES0006497122066058%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122066058&rfr_iscdi=true